2018-11-05
The "Pharmaceutical Administration Law of the People's Republic of China (Draft Amendment)" Has Been Officially Released
+2018-11-02
Hainan Xinshengquan International Cell Therapy Hospital Receives Clinical Approval for Stem Cells from the Health Bureau of the Logistics Support Department of the Central Military Commission
+2018-10-22
The Comprehensive Plan for China (Hainan) Free Trade Pilot Zone Published as a Standalone Book
The Comprehensive Plan for China (Hainan) Free Trade Pilot Zone Published as a Standalone Book
+2018-10-12
The mid-term review meeting for four key projects, including the National Key R&D Program's "Stem Cells and Translational Research," was held in Beijing in 2016.
+2018-10-12
Source: Economic Information Daily Jiuzhitang, a traditional Chinese medicine pharmaceutical company, has recently signed an investment agreement with U.S.-based Stemedica Cell Technologies Inc., a company based in San Diego’s Biotech Valley and boasting over a decade of experience in stem cell research, manufacturing, and marketing. Under the terms of the agreement, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. will introduce cutting-edge stem cell production technologies and a state-of-the-art preparation platform from one of the world’s leading stem cell firms. Over the next three to five years, Jiuzhitang Maker plans to establish a facility at the Beijing Daxing Biomedical Industry Base that meets both U.S. and EU cGMP standards.
+2018-10-11
Stem cells derived from baby teeth can be used to revive "dead" teeth.
Stem cells derived from baby teeth can be used to revive "dead" teeth.
+2018-09-30
The National Medical Products Administration has released the "Administrative Measures for Communication and Exchange in Drug Research and Development and Technical Review."
+2018-09-28
Over 50 major achievements have been implemented in Daxing's "China Pharma Valley."
Over 50 major achievements have been implemented in Daxing's "China Pharma Valley."
+2018-09-27
10 international cooperation projects officially signed and set to launch in China Pharmaceutical Valley.
+